Pepaxto

Active Ingredient(s): Melphalan Flufenamide
FDA Approved: * February 26, 2021
Pharm Company: * ONCOPEPTIDES AB
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Pepaxto Overview

Melphalan, sold under the trade name Alkeran among others, is a chemotherapy medication used to treat multiple myeloma, ovarian cancer, melanoma, and AL amyloidosis.[1] It is taken as a tablet (by mouth) or by injection into a vein.[1] Common side effects include nausea and bone marrow suppression.[1] Other severe side effects may include anaphylaxis and the development of other cancers.[1] Use during pregnancy may result in harm...

Read more Pepaxto Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Melphalan

Recent Pepaxto Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Melphalan Flufenamide
  • Injection: 20mg, 50mg, 50mg/vial
  • Powder: 20mg/vial, 50mg/vial
  • Tablet: 2mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Melphalan Flufenamide or a similar ingredient: (3 results)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 22 June 2021.

We are committed to your privacy.

Copyright © 2005-2021 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA